Skip to main content
. 2016 Jul 14;83(3):356–363. doi: 10.1016/j.bjorl.2016.05.012

Table 5.

Longitudinal studies focusing on PPI treatment.

Author Type Sample Selection criteria Measure Risk of bias/EBM level Result
Vaezi et al. (2010)33 Controlled randomized test 75 Postnasal drip with no CRS or allergy Symptoms evaluation and pH-metry using PPI High/ Important improvement of symptoms compared to control group
DiBaise et al. (2002)34 Cohort 11 CRS that is refractory to medical and surgical treatment Symptoms score, pH-metry via dual-channel tube, nasolaryngoscopy after PPI treatment for 3 months Mod/4 Mild improvement of symptoms
Pincus et al. (2006)35 Cohort 30 CRS that is refractory to medical and surgical treatment Evaluation of symptoms and pH-metry using PPI High/4 25 of 30 had LPR or nasal reflux events. 14 of 15 improved with PPI
Durmus et al. (2010)36 Case–control 50 vs. 30 GERD and LPR vs. absence of GERD Nasal saccharin test and clinical evaluation before and after treatment with PPI Mod/2b No difference on saccharin test. There was significant improvement of symptoms

CRS, chronic rhinosinusitis; LPR, laryngopharyngeal reflux; PPI, proton pump inhibitor; GERD, gastroesophageal reflux disease.